LCN2 and early-onset autosomal dominant Alzheimer disease: Studies have shown that blood levels of LCN2 protein increase with age and mild cognitive impairment in different diseases of the CNS, including Alzheimer’s disease, Parkinson’s disease and multiple sclerosis, and that brain tissue levels of LCN2 protein increase in people after death [37,40,41,42,43].